FeesSafety
Pluang+

Neumora submits IND for obesity drug NMRA-215 and reports Q3 net loss of $34.4M with $85.7M cash on hand

Company Fundamentals
16 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
Neumora submits IND for obesity drug NMRA-215 and reports Q3 net loss of $34.4M with $85.7M cash on hand

Neumora Therapeutics submitted an Investigational New Drug (IND) application for NMRA-215, a potential best-in-class oral NLRP3 inhibitor targeting obesity and cardiometabolic diseases. The company also reported positive dose-proportional exposure results for NMRA-511, a V1a receptor antagonist, supporting further development. For Q3 2026, Neumora posted a net loss of $34.4 million, down from $56.8 million in the prior year, with cash and equivalents of $85.7 million. The company is focused on advancing its pipeline while managing expenses and seeking additional funding for future development and commercialization.

Neumora Therapeutics' recent financial update is provided here alongside Pluang's Health-sector market snapshot. As of Nov 16, 2026 19:13 WIB, out of 150 priced Health-sector US stocks tradable on Pluang, 67 rose and 61 fell. Among notable movers, BioNano Genomics Inc (BNGO) gained 3.00% to USD 1.03 with a typical hold time of 52 days, contrasting with Guardant Health Inc (GH) which declined 3.18% to USD 147.01 and Hinge Health Inc (HNGE) down 2.72% at USD 112.25, with typical hold times of 10 and 12 days respectively.

More News

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
50 minutes ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
50 minutes ago
Rexel repurchases 3,878 own shares at an average price of €34.67 in early November 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 in early November 2026

Rexel Développement SAS announced it bought back a total of 3,878 of its own shares between November 9 and 13, 2026, at an average price of €34.67 per share. This share repurchase is part of the authorization granted by its shareholders to operate on...

Company Fundamentals
Neutral
50 minutes ago
SPIE acquires Duflex B.V. to boost industrial automation and robotics expertise in the Netherlands.

SPIE acquires Duflex B.V. to boost industrial automation and robotics expertise in the Netherlands.

SPIE, a leading European multi-technical services company, has acquired Duflex B.V., a Dutch firm specializing in industrial automation, machine construction, and robotics. This acquisition strengthens SPIE's capabilities in the industrial services v...

Company Fundamentals
Bullish
50 minutes ago
Hot-dip galvanized steel market for data centers to grow 12% CAGR, reaching $7.77B by 2036 driven by AI infrastructure demand.

Hot-dip galvanized steel market for data centers to grow 12% CAGR, reaching $7.77B by 2036 driven by AI infrastructure demand.

The global hot-dip galvanized steel market for data centers, valued at $2.05 billion in 2025, is projected to grow at a 12% CAGR to $7.77 billion by 2036. Growth is fueled by rapid AI data center construction, increasing power and cooling needs, and ...

Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App